Biognostix

the biognostix consortium is an eu funded project that will change the way diagnostic tests are performed. current diagnostic technology has some serious limitations. large volumes of sample and reagents are needed, with significant liquid handling and mixing steps. generally configured for lab use, existing diagnostics are optimised for doing a single test on a large group of patients. using our multiplex micro-fluidic platform and newly invented bioink, biognostix will deliver revolutionary fast, flexible, single-use tests in a format that anyone can use. in practice, biognostix combines biochemistry, microfludics and a novel particle technology platform to deliver a multiplex assay on a disposable paper-based analytical device (bgx-chip). the consortium has invented bioink – which contains engineered particles with attached biochemistry – and bioink-jet-printing to reliably and accurately deposit the test components on to the bgx-chip. tests can be colorimetric, densitometric or flu